CIMAX
Price
$26.20
Change
-$0.14 (-0.53%)
Updated
Jun 13 closing price
Net Assets
132.63B
HRLYX
Price
$9.28
Change
+$0.04 (+0.43%)
Updated
Jun 13 closing price
Net Assets
61.57M
Interact to see
Advertisement

CIMAX vs HRLYX

Header iconCIMAX vs HRLYX Comparison
Open Charts CIMAX vs HRLYXBanner chart's image
American Funds Income Fund of Amer 529A
Price$26.20
Change-$0.14 (-0.53%)
VolumeN/A
Net Assets132.63B
Hartford Real Asset Y
Price$9.28
Change+$0.04 (+0.43%)
VolumeN/A
Net Assets61.57M
CIMAX vs HRLYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIMAX vs. HRLYX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMAX is a Buy and HRLYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMAX has more cash in the bank: 133B vs. HRLYX (61.6M). CIMAX (3.73) and HRLYX (3.65) have matching dividends . CIMAX was incepted earlier than HRLYX: CIMAX (23 years) vs HRLYX (15 years). HRLYX (1.25) is less costly to investors than CIMAX (0.61). HRLYX is a more actively managed with annual turnover of: 198.00 vs. CIMAX (92.00). CIMAX has a lower initial minimum investment than HRLYX: CIMAX (250) vs HRLYX (250000). CIMAX annual gain was more profitable for investors over the last year : 13.65 vs. HRLYX (9.96). HRLYX return over 5 years is better than : 59.18 vs. CIMAX (48.27).
CIMAXHRLYXCIMAX / HRLYX
Total Expense Ratio0.610.9167%
Annual Report Gross Expense Ratio0.611.2549%
Fund Existence23 years15 years-
Gain YTD9.01012.89570%
Front Load4%N/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets133B61.6M215,909%
Annual Yield % from dividends3.733.65102%
Returns for 1 year13.659.96137%
Returns for 3 years27.4221.05130%
Returns for 5 years48.2759.1882%
Returns for 10 years68.1845.34150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCRX10.37-0.03
-0.29%
BioCryst Pharmaceuticals
ASNS0.67-0.02
-2.20%
Actelis Networks
STRT57.96-1.36
-2.29%
STRATTEC SECURITY Corp
DNA8.94-0.35
-3.77%
Ginkgo Bioworks Holdings
DAY57.08-2.51
-4.21%
Dayforce